I am interested in the field of biostatistics and clinical research, in particular in the statistical methods for observational studies and register-based research.

In my work with the Thrombosis Research Institute, I use real-world data to test different medications effectiveness and safety and to evaluate public health interventions in patients with atrial fibrillation. I also collaborate with the Duke Clinical Research Institute (US) for the development and validation of prediction models and clinical risk scores.

My PhD research is aimed to provide reliable and up-to-date global estimates of cancer cure indicators which are often missing from current survival statistics. These indicators will provide helpful information to public health planners in the evaluation of treatment, to oncologists in planning patients' follow-up, and to the increasing number of people living after a cancer diagnosis.